Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Neurotherapeutics
Metadata
Title
Measuring target effect of proposed disease-modifying therapies in Alzheimer’s disease
Authors
Randall J. Bateman
William E. Klunk
Publication date
01-07-2008
Publisher
Springer-Verlag
Published in
Neurotherapeutics / Issue 3/2008
Print ISSN: 1933-7213
Electronic ISSN: 1878-7479
DOI
https://doi.org/10.1016/j.nurt.2008.05.009

Other articles of this Issue 3/2008

Neurotherapeutics 3/2008 Go to the issue

Review Article

Inhibition and modulation of γ-secretase for Alzheimer’s disease

Review Article

Cholinergic treatments with emphasis on M1 muscarinic agonists as potential disease-modifying agents for Alzheimer’s disease

Review Article

Ketone bodies as a therapeutic for Alzheimer’s disease

Editorial

Novel therapeutics for Alzheimer’s disease

Review Article

β-Secretase as a therapeutic target for Alzheimer’s disease

Review Article

New therapeutic targets in the neurovascular pathway in Alzheimer’s disease